Search for: "Merck & Company, Inc"
Results 401 - 420
of 446
Sort by Relevance
|
Sort by Date
12 Oct 2007, 2:53 am
Merck & Co, Inc., No. 03-CA-009248 (Fla. [read post]
9 Oct 2007, 5:23 am
Inc. [read post]
8 Oct 2007, 5:49 pm
Australian Gold, Inc., 2:05-cv-1217 (E.D.N.Y. [read post]
4 Oct 2007, 11:13 am
In September 2007 Merck released its latest proclamation about the safety of Fosamax entitled "Fosamax: Statement by Merck & Co., Inc. [read post]
27 Sep 2007, 11:38 am
Merck & Co., slip op. at 10, 2007 WL 1181991 (Tex. [read post]
19 Sep 2007, 9:54 pm
(“Merck”). [read post]
13 Sep 2007, 10:48 am
Merck & Co., 2007 WL 2493917 (N.J. [read post]
7 Sep 2007, 12:48 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
5 Sep 2007, 7:39 am
These in-house attorneys have an exclusively legal function, whether it be supervising or managing litigation, reviewing company advertising or public statements, or revising contracts. [read post]
15 Aug 2007, 7:33 am
Merck & Co., Inc., No. [read post]
18 Jul 2007, 11:23 am
In re Merck & Co., Inc. [read post]
6 Jul 2007, 4:29 am
Hoffman-La Roche, Inc., 618 N. [read post]
28 Jun 2007, 12:26 pm
By Eric Goldman FragranceNet.com, Inc. v. [read post]
28 Jun 2007, 10:16 am
Merck & Co., 894 A.2d 1136 (N.J. [read post]
20 Jun 2007, 8:00 am
According to a person close to Apple, the company is expected to fight for this market, currently dominated by players like BlackBerry's RIM, Palm Inc. and, increasingly, Nokia Corp. and Motorola. [read post]
8 Jun 2007, 9:18 am
Cases against Vioxx maker Merck in Oregon had been barred by the statute of limitations. [read post]
6 Jun 2007, 8:49 am
While Merck was willing to offer a 30% discount on its $1.59 per pill price, the Brazilian government wanted it at $0.65 per pill — the rate at which the company supplies the drug in Thailand. [read post]
24 May 2007, 10:40 am
Vitek, Inc., 803 F. [read post]
27 Apr 2007, 1:25 pm
Earlier, Brazil threatened to break a patent for Kaletra, one of three anti-retrovirals made by Abbott Laboratories Inc. [read post]
27 Apr 2007, 12:04 pm
Amgen persuasively explained the position of his company in a scenario that is echoed by all major pioneer pharma and biotech entities and manifests the futility of any attempt to ram through Congress a one-size-fits-all "second" window solution. [read post]
